All You Need
In One Single
Theme.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat
Search here:

Author: Kirsten Dorsey

San Diego, CA, May 15, 2019 - L3 Clinical Trials, the Clinical Research Organization (CRO) division of L3 Healthcare (L3), announces the company is now a certified designer of the Medrio EDC Software. L3 Clinical Trials provides comprehensive and specialized CRO services for start-up and mid-size in vitrodiagnostic (IVD) and medical device companies. As a certified Medrio EDC designer, L3 Clinical Trials can now offer electronic data capture (EDC) and software customization to clinical trial sponsors using Medrio EDC, a leading...

L3 Healthcare is pleased to again participate in the American Association for Clinical Chemistry (AACC) annual meeting in Chicago.  L3 provides specialized in vitro diagnostics and medical device consulting services for organizations that are introducing new technologies or expanding existing business.  In addition to its consulting expertise in Quality, Regulatory Affairs, Market Development and Market Research, L3 is a full-service Clinical Research Organization (CRO). Our breadth of services provides our clients with core competencies to streamline projects and accelerate deliverables.  Meet...

San Diego, CA, April 25, 2017 – L3 Clinical Trials, the Clinical Research Organization (CRO) division of L3 Healthcare, is pleased to announce the company is now a certified iMedNet eClinical and Electronic Data Capture software designer for clinical trial data management.  The iMedNet software certification enables the company’s clinical research team to build, customize and manage clinical trial data capture and databases for clients.  In completing this certification, L3 Clinical Trials, continues to provide an integrated and comprehensive suite...

L3 Healthcare today announced the opening of L3 Healthcare Canada. The expansion of L3 Healthcare into Canada provides additional global services and support to L3 clients. The new office is headed by Managing Partner, Chermaen Lindberg, who has resided in Canada since 2006. “Our Canadian team members have a strong understanding of national regulations including Health Canada and International Conference of Harmonisation (ICH) guidelines,” says Chermaen Lindberg, “and our new office establishes a local presence for our clients undergoing clinical studies...